Stoke Therapeutics Inc

NASDAQ: STOK
$13.88
+$0.61 (+4.6%)
Closing Price on November 8, 2024

STOK Stock Chart and Intraday Price

STOK Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 3 PRESTON COURT, BEDFORD, MA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 340.71M USD
Shares Outstanding 44,653,800
Stoke Therapeutics Inc is a pioneering biopharmaceutical firm focused on developing innovative treatments for severe genetic diseases. With a unique approach using antisense oligonucleotides, the company aims to restore protein levels in patients. Its leading projects include STK-002 for autosomal dominant optic atrophy and STK-001 for Dravet syndrome, among others targeting central nervous system and eye diseases. Based in Bedford, Massachusetts, Stoke Therapeutics has formed a significant partnership with Acadia Pharmaceuticals to advance RNA-based medicines for rare neurodevelopmental conditions.

STOK Articles

Thursday's Top Analyst Upgrades and Downgrades: Albertsons, Alphabet, Apple, Coinbase, General Electric, McDonald's, Microsoft, Tesla and More
Thursday's top analyst upgrades and downgrades included Albertsons Companies, Alphabet, Apple, Coinbase Global, Danaher, Enphase Energy, GE HealthCare Technologies, General Electric, McDonald's,...
Lee Jackson
Published:

Monday's Top Analyst Upgrades and Downgrades: AT&T, ADM, Chevron, FedEx, Intel, Meta, Qualcomm and More
Monday's top analyst upgrades and downgrades included AT&T, ADM, Chevron, FedEx, Intel, Meta, Qualcomm and more.
Chris Lange
Published:

Barrick, Lyft, Nordstrom, Twitter and More Wednesday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including in Barrick, Nordstrom, Lyft and Twitter.
Chris Lange
Published: